Adil Abbasi, MD FACP

Learning Objectives

• Define hyponatremia and hypernatremia and understand their classification
• Explain the physiology of sodium and water balance
• Identify major etiologies of sodium disorders
• Recognize clinical manifestations, including neurologic complications
• Develop a structured diagnostic approach based on volume status and osmolality
• Formulate evidence-based management strategies with safe correction principles
• Understand special considerations in older adults and hospitalized patients

Introduction

Sodium disorders, including hyponatremia and hypernatremia, are among the most common electrolyte abnormalities encountered in clinical practice. They reflect disturbances in water balance rather than total body sodium content alone. Sodium is the principal extracellular cation and a key determinant of plasma osmolality, which governs water distribution between intracellular and extracellular compartments.

Hyponatremia is defined as a serum sodium concentration below 135 mEq/L, whereas hypernatremia is defined as a serum sodium concentration above 145 mEq/L. Both conditions can lead to significant morbidity and mortality, primarily due to their effects on the central nervous system.

The brain is particularly sensitive to changes in osmolality. Rapid shifts in sodium concentration can result in cerebral edema or cellular dehydration, leading to severe neurologic consequences. Therefore, accurate diagnosis and careful management are essential.

Physiology of Sodium and Water Balance

Water homeostasis is regulated by a complex interplay between thirst, antidiuretic hormone (ADH), and renal function. ADH, released from the posterior pituitary, promotes water reabsorption in the collecting ducts of the kidney, thereby concentrating urine and diluting plasma sodium.

The renin-angiotensin-aldosterone system regulates sodium balance by promoting sodium reabsorption in the distal nephron. Thirst mechanisms, triggered by increased plasma osmolality, drive water intake.

Disorders of sodium concentration typically arise from abnormalities in water balance rather than sodium intake. Excess water relative to sodium results in hyponatremia, while water deficit leads to hypernatremia.

Hyponatremia

Etiology

Hyponatremia is classified based on volume status: hypovolemic, euvolemic, and hypervolemic.

Hypovolemic hyponatremia occurs when both sodium and water are lost, but sodium loss exceeds water loss. Common causes include gastrointestinal losses, diuretic use, and adrenal insufficiency such as Addison’s disease.

Euvolemic hyponatremia is most commonly caused by the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Other causes include hypothyroidism and secondary adrenal insufficiency.

Hypervolemic hyponatremia occurs in conditions associated with fluid overload, such as heart failure, cirrhosis, and nephrotic syndrome, where effective circulating volume is reduced despite total body fluid excess.

Pathophysiology

Hyponatremia results from excess water relative to sodium. Increased ADH activity plays a central role, leading to water retention and dilution of serum sodium. In response, water shifts into cells, causing cellular swelling.

In the brain, this results in cerebral edema. Adaptive mechanisms allow brain cells to extrude osmolytes over time, reducing swelling in chronic hyponatremia. However, rapid development or correction can overwhelm these mechanisms.

Clinical Presentation

Symptoms depend on severity and rate of onset. Mild hyponatremia may be asymptomatic or present with nausea, headache, and fatigue.

Moderate to severe hyponatremia may cause confusion, vomiting, seizures, and coma. Acute hyponatremia is more likely to produce severe neurologic symptoms due to lack of cerebral adaptation.

Diagnostic Approach

Evaluation includes assessment of serum osmolality, volume status, and urine studies.

Table 1. Diagnostic Approach to Hyponatremia

Management

Treatment depends on severity and underlying cause. Severe symptomatic hyponatremia requires prompt treatment with hypertonic saline (3%) to prevent neurologic complications.

Chronic or mild hyponatremia is managed with fluid restriction, addressing underlying causes, and sometimes pharmacologic agents such as vasopressin antagonists.

Correction must be gradual to avoid osmotic demyelination syndrome. The general recommendation is not to exceed 8–10 mEq/L increase in serum sodium in 24 hours.

Hypernatremia

Etiology

Hypernatremia results from water loss or inadequate water intake.

Common causes include dehydration, impaired thirst, and conditions such as Diabetes insipidus. Poorly controlled Diabetes mellitus leads to osmotic diuresis and free water loss.

Older adults are particularly susceptible due to reduced thirst and limited access to fluids.

Pathophysiology

Hypernatremia reflects a deficit of water relative to sodium, leading to increased plasma osmolality. Water shifts out of cells, causing cellular dehydration.

In the brain, this results in shrinkage of brain cells, which may lead to tearing of cerebral vessels and intracranial hemorrhage. Adaptive mechanisms increase intracellular osmolytes over time in chronic cases.

Clinical Presentation

Symptoms include thirst, weakness, irritability, and altered mental status. Severe hypernatremia may cause seizures, coma, and death.

Neurologic symptoms are often more prominent in hypernatremia due to cellular dehydration.

Diagnostic Approach

Evaluation focuses on identifying the cause of water loss and assessing volume status.

Table 2. Diagnostic Clues in Hypernatremia

Management

The cornerstone of treatment is gradual correction of free water deficit.

Initial management may require isotonic fluids if the patient is hypovolemic, followed by hypotonic fluids such as D5W or half-normal saline.

Correction should be slow, generally not exceeding 10–12 mEq/L per day, to prevent cerebral edema.

Treatment of underlying causes, such as desmopressin for central diabetes insipidus or insulin for hyperglycemia, is essential.

Table 3. Key Differences: Comparison of Hyponatremia and Hypernatremia

Geriatric-Focused Approach

Older adults are at high risk for both hyponatremia and hypernatremia due to impaired thirst, reduced renal function, comorbidities, and polypharmacy.

Hyponatremia in older adults is often associated with medications such as diuretics and antidepressants, as well as SIADH. Even mild hyponatremia is associated with increased risk of falls, fractures, and cognitive impairment.

Hypernatremia frequently reflects inadequate fluid intake and is often a marker of frailty or impaired access to care. It is associated with high mortality rates in hospitalized elderly patients.

Management requires careful monitoring to avoid complications of overcorrection. Individualized treatment plans and attention to functional status and caregiving support are essential.

Complications

Both conditions can result in severe neurologic injury. Hyponatremia may lead to cerebral edema and herniation, while hypernatremia may cause intracranial hemorrhage and permanent neurologic damage.

Rapid correction of hyponatremia can cause osmotic demyelination syndrome, while rapid correction of hypernatremia can lead to cerebral edema.

Summary

Hyponatremia and hypernatremia are disorders of water balance with significant clinical implications. Hyponatremia results from excess water relative to sodium, while hypernatremia reflects water deficit.

Accurate diagnosis requires assessment of osmolality, volume status, and underlying causes. Management focuses on careful correction of sodium abnormalities while addressing the underlying condition.

Special attention is required in older adults, where these disorders are common, often multifactorial, and associated with increased morbidity and mortality.

References

Adrogué, H. J., & Madias, N. E. (2000). Hypernatremia. New England Journal of Medicine, 342(20), 1493–1499.

Adrogué, H. J., & Madias, N. E. (2000). Hyponatremia. New England Journal of Medicine, 342(21), 1581–1589.

Verbalis, J. G., et al. (2013). Diagnosis, evaluation, and treatment of hyponatremia. American Journal of Medicine, 126(10), S1–S42.

Spasovski, G., et al. (2014). Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrology Dialysis Transplantation, 29(Suppl 2), i1–i39.

Sterns, R. H. (2015). Disorders of plasma sodium. New England Journal of Medicine, 372(1), 55–65.